The chairman Lin Zhicheng(left) and Prof. Zhang Fujun(right)
In the noon of Dec. 29, the signing ceremony was successfully held in the headquarters of St. Stamford Modern Cancer Hospital Guangzhou. The leading expert of minimally invasive cancer treatment in China, Zhang Fujun was officially recruited in MCHG as chief expert of minimally invasive cancer treatment department. Prof. Zhang also acted as the chairman of committee of specialized minimally invasive cancer treatment in Chinese Anticancer Association and the director of Department of Radiation Oncology in Sun yat-sen University Cancer Hospital.
Leaders of China Boai Medical Group and St. Stamford Modern Cancer Hospital Guangzhou attended the signing ceremony included chairman Lin Zhicheng, medical director Lin Daoxuan and general manager of MCHG Lin Shaohua, hospital president Wang Huaizhong and multi-disciplinary experts Lin Taijie, Peng Xiaochi and Bai Haishan, etc.
Joint Photo of Attendees
Since the signing ceremony, Zhang Fujun has been officially recruited in St. Stamford Modern Cancer Hospital Guangzhou as chief expert of minimally invasive cancer treatment department. It also meant another step forward after MCHG became the first JCI-accredited China-Singapore Joint Venture hospital in Guangzhou.
St. Stamford Modern Cancer Hospital was founded in 2005 and it has over 10 offices in Southeast Asia. Equipped with cutting-edge cancer techniques, outstanding multidisciplinary team and high-quality humanistic service, the hospital integrates its international medical resources and cooperates with the leading expert of minimally invasive cancer treatment Prof. Zhang Fujun, so as to develop an international cooperated department of minimally invasive treatment for cancer, conduct diagnosis and treatment for intractable cancer and strengthen further cooperation in international cancer technologies. During the process of exploring further development in cancer treatment, St. Stamford Modern Cancer Hospital Guangzhou strives consistently to fight against the world enemy--cancer and to benefit more cancer patients.
The ceremony would further strengthen the leading status of St. Stamford Modern Cancer Hospital Guangzhou and also generate progress in Asian minimally invasive cancer treatment.
Prof. Zhang Fujun
Currently, Prof. Zhang Fujun serves as the chairman and secretary general of committee of specialized minimally invasive cancer treatment in Chinese Anticancer Association, the member and secretary of committee of specialized minimally invasive cancer treatment in Anticancer Association of Guangdong, the deputy director of particle therapy team in Chinese Anticancer Association, member of committee of specialized minimally invasive cancer treatment Guangzhou Anticancer Association, editorial board member of Minimally Invasive Surgery and executive member of editorial board of Imaging and Minimally Invasive Treatment for Cancer.
His research focuses on cancer therapies including CT-guided radioactive particle implantation, microwave ablation, radiofrequency ablation, HIFU therapy, interventional therapy and near-infrared fluorescence imaging of molecular targets.
Prof. Zhang Fujun was awarded with 3 national patents and Outstanding Contribution Award granted by committee of specialized minimally invasive cancer treatment in Chinese Anticancer Association. In addition, he wrote Interventional Therapy with CT Guide, Closely Interstitial Radioactive Seeds Treatment for Prostate Cancer, Combination of Minimally Invasive Treatment and Multidisciplinary Treatment for Liver Cancer. He also published over 50 professional academic papers in several leading magazine at home and abroad including Chinese Medical Journal, Cancer Biology and Therapy, Chinese Journal of Radiology, etc.